Y Q Kang1,2, Y M Zhang1, P Hou1, S F Shi1, L J Liu1, X J Zhou1, J C Lv1, H Zhang1. 1. Renal Department, Peking University First Hospital, Beijing 100034, China. 2. Renal Department, the Fourth Clinical Medical College of Guangzhou University of Chinese Medicine, Shenzhen 518033, China.
Abstract
OBJECTIVE: To compare the genetic architecture of susceptibility variants of IgA nephropathy (IgAN) in Chinese and Europeans. METHODS: We selected the independent genome-wide significant variants of IgAN in European population as candidate variants. Their associations, risk alleles, risk allele frequencies, odds ratios and population attributable risk scores were derived and calculated, then compared with those in the current Chinese population, including 1 194 IgAN patients and 902 controls. Using the significant variants, genetic risk scores were calculated and compared between the East Asians and the Europeans. The correlation between the genetic risk scores and clinical manifestations was also evaluated. RESULTS: There were 16 independent single nucleotide polymorphisms (SNPs) located in 11 loci showing significantly association with susceptibility to IgAN in the Europeans. 93.75% (15/16) of them also showed significant associations in the Chinese (P<0.05). The effects of all the associated SNPs were in the same direction, either risk or being protective for IgAN, between the Chinese and the Europeans. On the contrary, remarkable higher risk allelic odds ratio (P=1.94×10-2), higher risk allele frequency (P=3.09×10-2), and higher population attributable risk (P=3.03×10-4) were observed for most of the associated SNPs in the Chinese than in the Europeans. Furthermore, genetic risk scores were significantly larger in the Asian populations compared with the Europeans (P=1.78×10-163). While there was no significance among the subpopulations in both the East Asians and the Europeans. Compared with the healthy controls, the genetic risk score in the IgAN patients was significantly larger (P=3.60×10-27). Clinical analysis showed the genetic risk score was positively associated with serum levels of IgA and IgA1, phases of chronic kidney disease and Haas grades. CONCLUSION: Our study provides further evidence in the shared genetic architecture between Chinese and Europeans, while differences with respect to the effect sizes and risk allele frequencies across ethnicities, contributing partially to the differences of disease prevalence.
OBJECTIVE: To compare the genetic architecture of susceptibility variants of IgA nephropathy (IgAN) in Chinese and Europeans. METHODS: We selected the independent genome-wide significant variants of IgAN in European population as candidate variants. Their associations, risk alleles, risk allele frequencies, odds ratios and population attributable risk scores were derived and calculated, then compared with those in the current Chinese population, including 1 194 IgANpatients and 902 controls. Using the significant variants, genetic risk scores were calculated and compared between the East Asians and the Europeans. The correlation between the genetic risk scores and clinical manifestations was also evaluated. RESULTS: There were 16 independent single nucleotide polymorphisms (SNPs) located in 11 loci showing significantly association with susceptibility to IgAN in the Europeans. 93.75% (15/16) of them also showed significant associations in the Chinese (P<0.05). The effects of all the associated SNPs were in the same direction, either risk or being protective for IgAN, between the Chinese and the Europeans. On the contrary, remarkable higher risk allelic odds ratio (P=1.94×10-2), higher risk allele frequency (P=3.09×10-2), and higher population attributable risk (P=3.03×10-4) were observed for most of the associated SNPs in the Chinese than in the Europeans. Furthermore, genetic risk scores were significantly larger in the Asian populations compared with the Europeans (P=1.78×10-163). While there was no significance among the subpopulations in both the East Asians and the Europeans. Compared with the healthy controls, the genetic risk score in the IgANpatients was significantly larger (P=3.60×10-27). Clinical analysis showed the genetic risk score was positively associated with serum levels of IgA and IgA1, phases of chronic kidney disease and Haas grades. CONCLUSION: Our study provides further evidence in the shared genetic architecture between Chinese and Europeans, while differences with respect to the effect sizes and risk allele frequencies across ethnicities, contributing partially to the differences of disease prevalence.
Authors: John Feehally; Martin Farrall; Anne Boland; Daniel P Gale; Ivo Gut; Simon Heath; Ashish Kumar; John F Peden; Patrick H Maxwell; David L Morris; Sandosh Padmanabhan; Timothy J Vyse; Anna Zawadzka; Andrew J Rees; Mark Lathrop; Peter J Ratcliffe Journal: J Am Soc Nephrol Date: 2010-07-01 Impact factor: 10.121
Authors: Li Zhu; Wei-Yi Guo; Su-Fang Shi; Li-Jun Liu; Ji-Cheng Lv; Nicholas R Medjeral-Thomas; Hannah J Lomax-Browne; Matthew C Pickering; Hong Zhang Journal: Kidney Int Date: 2018-05-11 Impact factor: 10.612
Authors: Sampath Prahalad; Karen N Conneely; Yunxuan Jiang; Marc Sudman; Carol A Wallace; Milton R Brown; Lori A Ponder; Mina Rohani-Pichavant; Michael E Zwick; David J Cutler; Sheila T Angeles-Han; Larry B Vogler; Christine Kennedy; Kelly Rouster-Stevens; Carol A Wise; Marilynn Punaro; Ann M Reed; Elizabeth D Mellins; John F Bohnsack; David N Glass; Susan D Thompson Journal: Arthritis Rheum Date: 2013-06
Authors: Chuan Wang; Annika Ahlford; Tiina M Järvinen; Gunnel Nordmark; Maija-Leena Eloranta; Iva Gunnarsson; Elisabet Svenungsson; Leonid Padyukov; Gunnar Sturfelt; Andreas Jönsen; Anders A Bengtsson; Lennart Truedsson; Catharina Eriksson; Solbritt Rantapää-Dahlqvist; Christopher Sjöwall; Heikki Julkunen; Lindsey A Criswell; Robert R Graham; Timothy W Behrens; Juha Kere; Lars Rönnblom; Ann-Christine Syvänen; Johanna K Sandling Journal: Eur J Hum Genet Date: 2012-12-19 Impact factor: 4.246
Authors: Krzysztof Kiryluk; Yifu Li; Francesco Scolari; Simone Sanna-Cherchi; Murim Choi; Miguel Verbitsky; David Fasel; Sneh Lata; Sindhuri Prakash; Samantha Shapiro; Clara Fischman; Holly J Snyder; Gerald Appel; Claudia Izzi; Battista Fabio Viola; Nadia Dallera; Lucia Del Vecchio; Cristina Barlassina; Erika Salvi; Francesca Eleonora Bertinetto; Antonio Amoroso; Silvana Savoldi; Marcella Rocchietti; Alessandro Amore; Licia Peruzzi; Rosanna Coppo; Maurizio Salvadori; Pietro Ravani; Riccardo Magistroni; Gian Marco Ghiggeri; Gianluca Caridi; Monica Bodria; Francesca Lugani; Landino Allegri; Marco Delsante; Mariarosa Maiorana; Andrea Magnano; Giovanni Frasca; Emanuela Boer; Giuliano Boscutti; Claudio Ponticelli; Renzo Mignani; Carmelita Marcantoni; Domenico Di Landro; Domenico Santoro; Antonello Pani; Rosaria Polci; Sandro Feriozzi; Silvana Chicca; Marco Galliani; Maddalena Gigante; Loreto Gesualdo; Pasquale Zamboli; Giovanni Giorgio Battaglia; Maurizio Garozzo; Dita Maixnerová; Vladimir Tesar; Frank Eitner; Thomas Rauen; Jürgen Floege; Tibor Kovacs; Judit Nagy; Krzysztof Mucha; Leszek Pączek; Marcin Zaniew; Małgorzata Mizerska-Wasiak; Maria Roszkowska-Blaim; Krzysztof Pawlaczyk; Daniel Gale; Jonathan Barratt; Lise Thibaudin; Francois Berthoux; Guillaume Canaud; Anne Boland; Marie Metzger; Ulf Panzer; Hitoshi Suzuki; Shin Goto; Ichiei Narita; Yasar Caliskan; Jingyuan Xie; Ping Hou; Nan Chen; Hong Zhang; Robert J Wyatt; Jan Novak; Bruce A Julian; John Feehally; Benedicte Stengel; Daniele Cusi; Richard P Lifton; Ali G Gharavi Journal: Nat Genet Date: 2014-10-12 Impact factor: 38.330